|
Volumn 26, Issue 7, 1999, Pages 898-907
|
Phase I study of gemcitabine hydrochloride (LY 188011) combination therapy with cisplatin in the patients with non-small cell lung cancer
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG SCREENING;
FEMALE;
HUMAN;
LEUKOPENIA;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
NAUSEA;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
SQUAMOUS CELL CARCINOMA;
VOMITING;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
DRUG EVALUATION;
FEMALE;
HUMANS;
LEUKOPENIA;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NAUSEA;
NEUTROPENIA;
VOMITING, ANTICIPATORY;
|
EID: 0033143833
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|